File No. 37008/2021/Div.VI/NPPA
Government of India
Ministry of Chemicals & Fertilizers
Department of Pharmaceuticals
National Pharmaceutical Pricing Authority

3rd and 5th Floor,
YMCA Cultural Centre Building,
1, Jai Singh Road, New Delhi – 110 001

Dated: 17th April 2021

OFFICE MEMORANDUM

This is with reference to the ongoing efforts for enhancement of availability and affordability of ‘Remdesivir injection. On the intervention of the Government, the major manufacturers/marketers of ‘Remdesivir injection’ have reported voluntary reduction in Maximum Retail Price (MRP). The revised prices of major brands of ‘Remdesivir injection 100mg/Vial’ are as follows:

S.No. Name of the Company Brand
Name
Earlier
MRP (Rs.)
Revised
MRP
1. Cadila Healthcare Ltd REMDAC 2,800/- 899/-
2. Syngene International Ltd (Biocon Biologics India) RemWin 3,950/- 2,450/-
3.  Dr. Reddy’s Laboratories Ltd REDYX 5,400/- 2,700/-
4. Cipla Ltd CIPREMI 4,000/- 3,000/-
5. Mylan Pharmaceuticals Pvt Ltd DESREM 4,800/- 3,400/-
6. Jubilant Generics Ltd JUBI-R 4,700/- 3,400/-
7. Hetero Healthcare Ltd COVIFOR 5,400/- 3,490/-

(Dr. Vinod Kotwal)

Member Secretary

To

Drug Controller / Food & Drug Administration of all State / UT Governments for information and compliance

Copy for information to:

  1. PPS to Hon’ble Minister (HCF)
  2. PPS to Hon’ble Minister of State (HCF)
  3. Secretary (Pharma), Gol
  4. Secretary (Health),GoI
  5. Pr. Health Secretaries (All States/UTs)
  6. Drug Controller General (India)
Tags:

More Under Corporate Law

Leave a Comment

Your email address will not be published. Required fields are marked *

Search Posts by Date

May 2021
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31